文献速递头颈甲状腺与浅表技术与安全USSPECT/CT

超声与治疗后碘-131 SPECT/CT 对甲状腺乳头状癌颈部淋巴结转移检出率的比较

A Comparison of Detection Rates Between Ultrasound and Post-Therapeutic I-131 SPECT/CT for Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.
PubMed 文献 · J Ultrasound Med · 2026-03-13

回顾性参考标准导向队列研究纳入 172 例甲状腺切除术后甲状腺乳头状癌患者,分析 266 枚病理证实转移的淋巴结,超声检出率 75.0% 高于 SPECT/CT 的 55.8%(P < .001),微钙化与低回声是超声判定可疑的独立预测因素,VI 区最常受累(55%)。

要点

  • 超声对病理证实转移淋巴结的检出率 75.0%,高于 SPECT/CT 的 55.8%(P < .001)。
  • 微钙化(aOR=1.64,P=.03)与低回声(aOR=1.57,P=.02)是超声判定可疑的独立预测因素。
  • VI 区是最常受累淋巴结区(55%),也是转移受累的唯一独立预测因素(OR=2.64,P=.028)。

核心结论

  • 超声对转移淋巴结的检出优于 SPECT/CT,并识别出 SPECT/CT 漏诊的 32.7% 放射性碘难治性疾病亚组;SPECT/CT 仍有助于确认放射性碘摄取和检出隐匿功能性病变,作者认为这些发现支持根据转移特征采用联合影像策略。

研究设计与样本

  • 回顾性、参考标准导向的队列研究,纳入 172 例甲状腺切除术后甲状腺乳头状癌患者,分析 266 枚病理证实转移的淋巴结,比较超声与治疗后碘-131 SPECT/CT 的检出率(McNemar 检验),并用多因素 logistic 回归分析超声判定可疑的独立预测因素。

关键影像表现/征象

  • 微钙化(aOR=1.64,P=.03)和低回声(aOR=1.57,P=.02)是淋巴结被超声判定为可疑的最强独立预测因素。
  • VI 区是最常受累的淋巴结区(55%),也是转移受累的唯一独立预测因素(OR=2.64,P=.028)。

诊断标准与关键数值

  • 超声对病理证实转移淋巴结的检出率为 75.0%,SPECT/CT 为 55.8%,差异有统计学意义(P < .001)。
  • 超声识别出 SPECT/CT 漏诊的放射性碘难治性疾病亚组占 32.7%。
  • 微钙化预测超声判定可疑的校正比值比为 1.64(P=.03),低回声为 1.57(P=.02)。
  • VI 区预测转移受累的比值比为 2.64(P=.028)。

临床应用与阅片要点

  • 作者认为这些发现支持根据转移特征采用超声与 SPECT/CT 联合的影像策略。
  • 超声判定可疑淋巴结时,微钙化和低回声是需要关注的声像图特征。
  • VI 区是最常受累且可预测的转移部位,阅片时应注意该区域的淋巴结评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study compares the diagnostic performance of Ultrasound and post-therapeutic I-131 SPECT/CT for detecting cervical lymph node metastases in postoperative patients. We also characterize the sonographic features of metastatic nodes and map their distribution across cervical levels.

METHODS: A retrospective, reference-standard-led cohort study was conducted. The cohort comprised 172 post-thyroidectomy PTC patients, from which 266 individual lymph nodes with pathologically proven metastasis were analyzed. The detection rates of US and I-131 SPECT/CT were compared using McNemar's test. Multivariate logistic regression was used to identify independent sonographic predictors of a node being classified as suspicious on ultrasound.

RESULTS: US demonstrated a significantly higher detection rate for proven metastatic nodes than SPECT/CT (75.0% versus 55.8%, P < .001). Microcalcifications [adjusted odds ratio (aOR) = 1.64, P = .03] and hypoechogenicity (aOR = 1.57, P = .02) were the strongest independent predictors of a node being classified as suspicious on ultrasound. Level VI was the most frequently involved nodal station (55%) and the only independent predictor of metastatic involvement (OR = 2.64, P = .028).

CONCLUSION: Ultrasound demonstrated superior detection of metastatic lymph nodes, identifying a substantial subset (32.7%) of RAI-refractory disease missed by SPECT/CT. SPECT/CT remains valuable for confirming RAI avidity and detecting occult functional disease. These findings support a combined imaging strategy according to the metastatic characteristics. The presence of microcalcifications and hypoechogenicity was an important sonographic predictor of malignancy, with Level VI being the most common and predictable site of metastatic involvement.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Upadhyaya A, Dong Q, Sang R, et al. A Comparison of Detection Rates Between Ultrasound and Post-Therapeutic I-131 SPECT/CT for Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma. J Ultrasound Med. 2026. PMID: 41826241. doi:10.1002/jum.70226

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。